(Reuters) – Moderna Inc said Tuesday that it has received a report from the California Department of Health that several people are being treated at a center in San Diego for possible allergic reactions to the COVID-19 vaccine from a specific group.
The company’s comments come after the top epidemiologist in California on Sunday issued a statement recommending that suppliers vaccinate under no. 41L20A due to possible allergic reactions being investigated.
“A higher than usual number of possible allergic reactions have been reported with a specific amount of Moderna vaccine administered at one community vaccination clinic. Less than ten individuals required medical assistance over 24 hours,” the epidemiologist said in a statement here. .
The vaccine manufacturer said he was unaware of similar cases of adverse events from other vaccination centers that may have administered vaccines of the same fate or from other vaccines.
A total of 307,300 doses of the lot remain, according to Moderna, of the total 1,272,200 doses produced in the group.
Moderna said it is working closely with U.S. health regulators to understand the cases and whether the use of the lot should be discontinued.
Nearly one million doses of the site have already been distributed in approximately 1,700 vaccination sites in 37 states, Moderna said. (bit.ly/39MPtlF)
Reporting by Manojna Maddipatla in Bengaluru; Edited by Vinay Dwivedi and Shinjini Ganguli